Data Year:
Select Other Years

For its 2022 fiscal year, NANOSTRING TECHNOLOGIES INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2022
Name And Title Total Compensation Pay Rank By Title In Biotechnology industry
R. Bradley Gray
President and Chief Executive Officer
Total Compensation $7,596,268 View details Pay Rank By Title In Biotechnology industry #169 View more
J. Chad Brown
Senior Advisor (Former Senior Vice President, Sales and Marketing)
Total Compensation $154,780 View details Pay Rank By Title In Biotechnology industry #11 View more
Joseph M. Beechem
Chief Scientific Officer and Senior Vice President, Research & Development
Total Compensation $2,318,070 View details Pay Rank By Title In Biotechnology industry #3 View more
K. Thomas Bailey
Chief Financial Officer
Total Compensation $2,318,070 View details Pay Rank By Title In Biotechnology industry #217 View more
John Gerace
Chief Commercial Officer
Total Compensation $3,800,594 View details Pay Rank By Title In Biotechnology industry #67 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at NANOSTRING TECHNOLOGIES INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. NANOSTRING TECHNOLOGIES INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. NANOSTRING TECHNOLOGIES INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
R. Bradley Gray
President and Chief Executive Officer
Total Cash $1,056,188 Equity $6,536,080 Other $4,000 $7,596,268
J. Chad Brown
Senior Advisor (Former Senior Vice President, Sales and Marketing)
Total Cash $150,780 Equity $0 Other $4,000 $154,780
Joseph M. Beechem
Chief Scientific Officer and Senior Vice President, Research & Development
Total Cash $633,406 Equity $1,680,664 Other $4,000 $2,318,070
K. Thomas Bailey
Chief Financial Officer
Total Cash $633,406 Equity $1,680,664 Other $4,000 $2,318,070
John Gerace
Chief Commercial Officer
Total Cash $574,976 Equity $3,161,618 Other $64,000 $3,800,594
For its 2022 fiscal year, NANOSTRING TECHNOLOGIES INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
R. Bradley Gray CEO Pay $7,596,268 Median Employee Pay $141,124 CEO Pay Ratio 54:1
For its 2022 fiscal year, NANOSTRING TECHNOLOGIES INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Charles P. Waite Total Cash $243,855
Dana Rollison, Ph.D. Total Cash $228,855
Don R. Kania Total Cash $21,944
Elisha Finney Total Cash $243,855
Gregory Norden Total Cash $238,855
Janet George Total Cash $233,855
Kirk D. Malloy, Ph.D. Total Cash $231,355
Robert M. Hershberg Total Cash $83,190
Teresa Foy Total Cash $306,441
William D. Young Total Cash $276,355
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.